News
ADMA Biologics Highlights Launch of COVID-19 ImmunoRank Neutralization MICRO-ELISA Assay to Detect SARS-CoV-2 Neutralizing Antibodies in Plasma
ADMA Biologics, Inc., an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, today announced the launch of COVID-19 ImmunoRank Neutralization...
News
UNICEF to lead procurement and supply of COVID-19 vaccines in world’s largest and fastest ever operation of its kind
UNICEF is leading efforts to procure and supply COVID-19 vaccines in what could possibly be the world’s largest and fastest ever procurement and supply of...
News
Mesoblast Limited receives ethics approval to treat COVID-19 patients in Australia
Mesoblast Limited, global leader in allogeneic cellular medicines for inflammatory diseases, announced that it has received ethics approval to include Australian hospitals in thePhase 3...
News
Delivery of COVID-19 vaccine: DHL study shows how public and private sector can partner for success
With first emergency use authorizations for COVID-19 vaccines expected to be effective in the last quarter of 2020, logistics providers are challenged to rapidly establish...
Clinical Trials
Bharat Biotech gets approval to conduct phase 2 trials of COVID-19 vaccine Covaxin
Hyderabad-based Bharat Biotech has received approval to conduct phase II trials of its COVID-19 vaccine Covaxin from September 7.
The Directorate General of Health Service said...
Clinical Trials
Early trials find Russia’s Sputnik V safe, volunteers develop coronavirus antibodies within 3 weeks
Much buzz was created around the world when Russia claimed to have approved the first COVID-19 vaccine around the world, for public use. Experts and...
News
CureVac to Receive 252million Euros to Support COVID-19 Vax Development
CureVac N.V., a biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) in clinical trials, has received notification from...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.